TY - JOUR
T1 - Announcing the Biomedical Data Translator
T2 - Initial Public Release
AU - The Biomedical Data Translator Consortium
AU - Fecho, Karamarie
AU - Glusman, Gwênlyn
AU - Baranzini, Sergio E.
AU - Bizon, Chris
AU - Brush, Matthew
AU - Byrd, William
AU - Chung, Lawrence
AU - Crouse, Andrew
AU - Deutsch, Eric
AU - Dumontier, Michel
AU - Foksinska, Aleksandra
AU - Hadlock, Jennifer
AU - He, Kaiwen
AU - Huang, Sui
AU - Hubal, Robert
AU - Hyde, Gregory M.
AU - Israni, Sharat
AU - Kenmogne, Kelyne
AU - Koslicki, David
AU - Marcette, Jana Dorfman
AU - Mathe, Ewy A.
AU - Mesbah, Abrar
AU - Moxon, Sierra A.T.
AU - Mungall, Christopher J.
AU - Osborne, John
AU - Pasfield, Carrie
AU - Qin, Guangrong
AU - Ramsey, Stephen A.
AU - Reese, Justin
AU - Roach, Jared C.
AU - Rose, Reese
AU - Soman, Karthik
AU - Su, Andrew I.
AU - Ta, Casey
AU - Vaidya, Gaurav
AU - Weber, Rosina
AU - Wei, Qi
AU - Williams, Mark
AU - Wu, Chunlei
AU - Xu, Colleen
AU - Yakaboski, Chase
AU - Arab, Michel
AU - Abdollahi, Shervin
AU - Acosta, Nichollette
AU - Agrawal, Ayushi
AU - Ahalt, Stanley
AU - Amin, Nada
AU - Bada, Michael
AU - Balar, Krish
AU - Balhoff, Jim
N1 - Publisher Copyright:
© 2025 The Author(s). Clinical and Translational Science published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics.
PY - 2025/7
Y1 - 2025/7
N2 - The growing availability of biomedical data offers vast potential to improve human health, but the complexity and lack of integration of these datasets often limit their utility. To address this, the Biomedical Data Translator Consortium has developed an open-source knowledge graph–based system—Translator—designed to integrate, harmonize, and make inferences over diverse biomedical data sources. We announce here Translator's initial public release and provide an overview of its architecture, standards, user interface, and core features. Translator employs a scalable, federated, knowledge graph framework for the integration of clinical, genomic, pharmacological, and other biomedical knowledge sources, enabling query retrieval, inference, and hypothesis generation. Translator's user interface is designed to support the exploration of knowledge relationships and the generation of insights, without requiring deep technical expertise and gradually revealing more detailed evidence, provenance, and confidence information, as needed by a given user. To demonstrate Translator's application and impact, we highlight features of the user interface in the context of three real-world use cases: suggesting potential therapeutics for patients with rare disease; explaining the mechanism of action of a pipeline drug; and screening and validating drug candidates in a model organism. We discuss strengths and limitations of reasoning within a largely federated system and the need for rich concept modeling and deep provenance tracking. Finally, we outline future directions for enhancing Translator's functionality and expanding its data sources. Translator represents a significant step forward in making complex biomedical knowledge more accessible and actionable, aiming to accelerate translational research and improve patient care.
AB - The growing availability of biomedical data offers vast potential to improve human health, but the complexity and lack of integration of these datasets often limit their utility. To address this, the Biomedical Data Translator Consortium has developed an open-source knowledge graph–based system—Translator—designed to integrate, harmonize, and make inferences over diverse biomedical data sources. We announce here Translator's initial public release and provide an overview of its architecture, standards, user interface, and core features. Translator employs a scalable, federated, knowledge graph framework for the integration of clinical, genomic, pharmacological, and other biomedical knowledge sources, enabling query retrieval, inference, and hypothesis generation. Translator's user interface is designed to support the exploration of knowledge relationships and the generation of insights, without requiring deep technical expertise and gradually revealing more detailed evidence, provenance, and confidence information, as needed by a given user. To demonstrate Translator's application and impact, we highlight features of the user interface in the context of three real-world use cases: suggesting potential therapeutics for patients with rare disease; explaining the mechanism of action of a pipeline drug; and screening and validating drug candidates in a model organism. We discuss strengths and limitations of reasoning within a largely federated system and the need for rich concept modeling and deep provenance tracking. Finally, we outline future directions for enhancing Translator's functionality and expanding its data sources. Translator represents a significant step forward in making complex biomedical knowledge more accessible and actionable, aiming to accelerate translational research and improve patient care.
UR - https://www.scopus.com/pages/publications/105010974964
UR - https://www.scopus.com/pages/publications/105010974964#tab=citedBy
U2 - 10.1111/cts.70284
DO - 10.1111/cts.70284
M3 - Short survey
C2 - 40635371
AN - SCOPUS:105010974964
SN - 1752-8054
VL - 18
JO - Clinical and Translational Science
JF - Clinical and Translational Science
IS - 7
M1 - e70284
ER -